RE:RE:Roll back to uplist?
A rollback should be in the cards if Roger wants institutional buying etc. With the stock price not showing any love to the recent clinical results (except for the AM run on the news release) the stock won't be moving a much as many believe if they hit the motherlode. Too many stages and phases and institutions won't be able to buy until it's over a certain price. The only way to accelerate that buying will be a major reback.
In a smaller but similar comparison, nice to see Theralase is congratulated with its move today by going down 2+ cents. Two good pieces of news and the SP goes down. One hopes that a cancer cure does not happen, the stock will go to "0" (LOL)